Futoshi Shibata
Profile
Performance in office
Tenure
Tenure
Background
He joined Cosmos Pharmaceutical in November 1998 and became General Manager of Corporate Planning in July 2006. He became a Director in August 2012 and Representative Director and President in August 2017, 19 years after joining. From June 2012 to August 2019 he also served as Representative Director of group company Green Flash. He was a career employee with long experience in corporate planning.
Selection
In August 2017 he replaced Masaaki Uno as Representative Director and President. In the FY ended May 2017, the year before he took office, consolidated net sales were ¥502.7 billion and operating income ¥22.2 billion, up in two years from ¥408.4 billion and ¥17.1 billion in the FY ended May 2015. In the FY ended May 2015, the top shareholders were Hidefuji Ltd. at 32.74% and Yukitaka Uno at 10.48%, Masaaki Uno himself held 2.99%, and Shibata was not in the top ten.
Initiatives
His tenure as President lasted only one period, the FY ended May 2018. In that year consolidated net sales were ¥557.9 billion and operating income ¥22.7 billion, up in both from ¥502.7 billion and ¥22.2 billion the year before. In June 2018 he stepped back to Director, and Hideaki Yokoyama succeeded him.
Career
Career
Cosmos Pharmaceutical
| Date | Position |
|---|---|
| Nov 1998 | Joined |
| Jul 2006 | General Manager, Corporate Planning Department |
| Aug 2012 | Director |
| Aug 2017 | Representative Director, President |
| Jun 2018 | Director |
| Jun 2018 | Stepped down as President |
Gurinfurasshu
| Date | Position |
|---|---|
| Jun 2012 | Representative Director |
| Aug 2019 | Director |
References 1
References (Japanese primary sources)
- コスモス薬品 有価証券報告書【役員の状況】